A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects

NCT02496221 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Albiglutide 50 mg
DRUG: Placebo
DRUG: CCK (Kinevac)

Sponsor

GlaxoSmithKline